Neurotrope Stock Price - NTRP

1.35
0.02 (1.50%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Neurotrope Inc NTRP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.08 6.4% 1.33 1.24 1.39 1.26 1.25 00:00:04
Bid Price Ask Price Spread Spread % News
1.01 1.45 0.44 30.34% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,498 757,111 $ 1.34 $ 1,012,370 2,093,065 0.59 - 8.41
Last Trade Time Type Quantity Stock Price Currency
19:36:12 formt 300 $ 1.35 USD

Neurotrope Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 17.38M 13.07M $ -11.02M -1.37 - 13.06M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Neurotrope News

Loading Messages....

Latest NTRP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NTRP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.171.391.121.22326,3950.1613.68%
1 Month1.351.431.051.22414,960-0.02-1.48%
3 Months0.813.850.74471.371,222,8160.5264.2%
6 Months5.706.000.591.27845,156-4.37-76.67%
1 Year4.298.410.591.73473,354-2.96-69.0%
3 Years19.0021.39990.592.92199,993-17.67-93.0%
5 Years19.0021.39990.592.92199,993-17.67-93.0%

Neurotrope Description

Neurotrope Inc is a biopharmaceutical company. The company is principally focused on developing a product platform based on a drug candidate called bryostatin for the treatment of Alzheimer's disease ("AD"), which is in the clinical testing stage. It is also developing bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C, which are in pre-clinical testing.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.